Deliver Your News to the World

CybeRelease: (OTC: TEDG) Gets SFDA Approval to Deliver Flu Vaccine


(CybeRelease, August 31, 2006) - Lake Harmony, PA - China Biopharma Inc. (OTCBB: TEDG) today announced that Zhejiang Tianyuan Biopharmaceutical, the Company’s manufacturing joint venture partner, received approval from the Chinese State Food and Drug Administration (SFDA) to deliver its flu vaccine product for the first batch release of the 2006-2007 influenza season. The Company commenced shipping of the first lots of its flu vaccine product last week to local Centers for Disease Control & Prevention (China CDCs) and hospitals.

“We are very pleased that our flu vaccine is among the first to be delivered and made available to the general public in China this season,” said Dr. Jean-Denis Shu, chief executive officer and chief scientist of China Biopharma’s China operation. “We believe our flu vaccine will prove beneficial to many this year, and expect that physicians will adopt the China CDCs recent recommendations to begin immunizing against influenza as soon as the vaccine is available.”

To read the complete release, go to

For a Free Newsletter and more information, go to

CybeRelease Gainers are Rambus, Inc. (Nasdaq: RMBS), Lam Research Corporation (Nasdaq: LRCX), Sigma Designs, Inc. (Nasdaq: SIGM), Merge Technologies Inc. (Nasdaq: MRGE), Novavax, Inc. (Nasdaq: NVAX), ANADIGICS, Inc. (Nasdaq: ANAD), Credence Systems Corporation (Nasdaq: CMOS) and Energy Conversion Devices, Inc. (Nasdaq: ENER).

CybeRelease Decliners are Costco Wholesale Corporation (Nasdaq: COST), ADC Telecommunications, Inc. (Nasdaq: ADCT), VA Software Corporation (Nasdaq: ), Travelzoo Inc. (Nasdaq: TZOO), NutriSystem Inc. (Nasdaq: NTRI), Swift Transportation Co., Inc. (Nasdaq: SWFT), Sycamore Networks, Inc. (Nasdaq: SCMR) and United Natural Foods, Inc. (Nasdaq: UNFI).

Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor’s reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. A third party has hired and paid CybeRelease $500.00 for the publication of this report. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have no ownership of equity, no representation and do no trading of any kind.


This news content may be integrated into any legitimate news gathering and publishing effort. Linking is permitted.

News Release Distribution and Press Release Distribution Services Provided by WebWire.